The pathway for developing new medications and moving
from idea to preclinical development tests, complicated
clinical trials, and regulatory approval by the FDA is often
an expensive and long road. In fact, industry research notes
this process can take several years – usually 10 to 15 – and
hundreds of millions of dollars. For an organization needing
to move a drug quickly to market or struggling to overcome
the hurdles that can arise during a clinical trial, it can seem
like an uphill battle to the finish line.
With both time and money at stake, organizations need
a clinical research organization (CRO) partner that has a
proven record of successfully operating under significant time
constraints, while still delivering a high-quality and successful
clinical trial, moving an agent from proof of concept (POC)
through to New Drug Application (NDA) status quickly and
efficiently.
Download case study:
